Search Results 2141-2150 of 38969 for ms
... ms for males and >470 ms for females at Screening Visit 2 or QTcF ≥480 ms for participants with bundle branch block. 27. Clinically important abnormalities ...
Grotz, M.D., M.S.. Surgical Oncologist. Rochester, MN ...
Julie Ann Vera, M.S.. January 28, 2025. Mayo Clinic opens new doors in cancer treatment innovation featured image. Individualized Medicine. Mayo Clinic opens ...
... MS/MS), and real-time polymerase chain reaction (PCR). The Pharmacology Shared Resource contributes to clinical trials sponsored by the Alliance for ...
Grotz, M.D., M.S.. Surgical Oncologist. Rochester, MN. Areas of focus: Robotic surgery, Hyperthermic intraperitoneal chemotherapy, ...
Sherif A. El Nashar, M.B., B.Ch., M.S.. Gynecologist; Urogynecologist. Jacksonville, FL ...
... multiple sclerosis (MS). Participants will be randomized at a 1 to 1 (1:1) ratio. All participants will be followed for 72 months after randomization (Day 0 ...
McKenna, M.D., M.S.. Colon and Rectal Surgeon. Rochester, MN ...
Tan, M.D., M.S.. Cardiac Electrophysiologist. Rochester, MN. Areas of focus: Atrial fibrillation ablation, Atrial flutter ablation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.